NAEOTOM Alpha.Prime Software applications: syngo.CT Brain Quantification syngo.CT Vessel Hyperdensities syngo.CT ASPECTS
To remove the software applications from certain CT systems as the applications have not received FDA 510(k) clearance.
Worldwide distribution - US Nationwide and the countries of Canada, Costa Rica, India, Israel.
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1241-2026